Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders.
Petitt
R M
RM
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Silverstein
M N
MN
Petrone
M E
ME
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011086:Polycythemia / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D013922:Thrombocytosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D011799:Quinazolines; C021139:anagrelide